AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 200 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,040 | -18.2% | 350 | 0.0% | 0.00% | – |
Q4 2022 | $9,828 | -10.7% | 350 | +75.0% | 0.00% | – |
Q2 2021 | $11,000 | +22.2% | 200 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | -74.3% | 200 | -80.0% | 0.00% | -100.0% |
Q3 2020 | $35,000 | -2.8% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $36,000 | -25.0% | 1,000 | 0.0% | 0.00% | -33.3% |
Q4 2019 | $48,000 | +1100.0% | 1,000 | +1150.0% | 0.00% | – |
Q3 2019 | $4,000 | 0.0% | 80 | 0.0% | 0.00% | – |
Q2 2019 | $4,000 | -20.0% | 80 | 0.0% | 0.00% | – |
Q1 2019 | $5,000 | +25.0% | 80 | 0.0% | 0.00% | – |
Q4 2018 | $4,000 | -33.3% | 80 | 0.0% | 0.00% | – |
Q3 2018 | $6,000 | -14.3% | 80 | 0.0% | 0.00% | -100.0% |
Q2 2018 | $7,000 | 0.0% | 80 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $7,000 | +40.0% | 80 | 0.0% | 0.00% | – |
Q4 2017 | $5,000 | +150.0% | 80 | +166.7% | 0.00% | – |
Q3 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q2 2017 | $2,000 | 0.0% | 30 | 0.0% | 0.00% | – |
Q1 2017 | $2,000 | – | 30 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |